Medical-equipment maker Biomet ( BMET) reported record third-quarter earnings Wednesday, but just edged past analysts' expectations. The Indiana-based company had net income of $86.6 million, or 34 cents a share, on revenue of $410.2 million, vs. $72.6 million, or 28 cents a share, on revenue of $354 million a year ago. The consensus estimate was 33 cents a share in the quarter ended Feb. 29, according to Thomson One Analytics. For the fourth quarter, the company forecast EPS of 34 cents to 36 cents, vs. a consensus estimate of 35 cents a share, and revenue of $420 million to $438 million, compared with analysts' forecasts of $429 million. The weak dollar increased third-quarter sales by $17.9 million. Sales of reconstructive devices increased 22% worldwide. The company said sales "continue to be led by strong growth in the Company's reconstructive, spinal hardware and orthobiologic product lines." Shares rose $1.36, or 3.5%, to $39.20 Tuesday.